0
Your cart

Your cart is empty

Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics

Buy Now

Oversight and Review of Clinical Gene Transfer Protocols - Assessing the Role of the Recombinant DNA Advisory Committee (Paperback) Loot Price: R1,184
Discovery Miles 11 840
Oversight and Review of Clinical Gene Transfer Protocols - Assessing the Role of the Recombinant DNA Advisory Committee...

Oversight and Review of Clinical Gene Transfer Protocols - Assessing the Role of the Recombinant DNA Advisory Committee (Paperback)

Institute of Medicine, Board on Health Sciences Policy, Committee on the Independent Review and Assessment of the Activities of the Nih Recombinant DNA Advisory Committee; Edited by Lawrence O. Gostin, Bruce M Altevogt, Rebecca N. Lenzi

 (sign in to rate)
Loot Price R1,184 Discovery Miles 11 840 | Repayment Terms: R111 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

Gene transfer research is a rapidly advancing field that involves the introduction of a genetic sequence into a human subject for research or diagnostic purposes. Clinical gene transfer trials are subject to regulation by the U.S. Food and Drug Administration (FDA) at the federal level and to oversight by institutional review boards (IRBs) and institutional biosafety committees (IBCs) at the local level before human subjects can be enrolled. In addition, at present all researchers and institutions funded by the National Institutes of Health (NIH) are required by NIH guidelines to submit human gene transfer protocols for advisory review by the NIH Recombinant DNA Advisory Committee (RAC). Some protocols are then selected for individual review and public discussion. Oversight and Review of Clinical Gene Transfer Protocols provides an assessment of the state of existing gene transfer science and the current regulatory and policy context under which research is investigated. This report assesses whether the current oversight of individual gene transfer protocols by the RAC continues to be necessary and offers recommendations concerning the criteria the NIH should employ to determine whether individual protocols should receive public review. The focus of this report is on the standards the RAC and NIH should use in exercising its oversight function. Oversight and Review of Clinical Gene Transfer Protocols will assist not only the RAC, but also research institutions and the general public with respect to utilizing and improving existing oversight processes. Table of Contents Front Matter Summary 1 Introduction 2 Gene Transfer Research: The Evolution of the Clinical Science 3 Oversight of Gene Transfer Research 4 Evolution of Oversight of Emerging Clinical Research Appendix A: Data Sources and Methods Appendix B: Historical and Policy Timelines for Recombinant DNA Technology Appendix C: Committee Biographies

General

Imprint: National Academies Press
Country of origin: United States
Release date: April 2014
Authors: Institute of Medicine • Board on Health Sciences Policy • Committee on the Independent Review and Assessment of the Activities of the Nih Recombinant DNA Advisory Committee
Editors: Lawrence O. Gostin • Bruce M Altevogt • Rebecca N. Lenzi
Dimensions: 229 x 152 x 10mm (L x W x T)
Format: Paperback
Pages: 134
ISBN-13: 978-0-309-29662-5
Categories: Books > Medicine > Pre-clinical medicine: basic sciences > Medical genetics
Books > Medicine > General issues > Medical equipment & techniques > Medical research
LSN: 0-309-29662-5
Barcode: 9780309296625

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners